It’s been a year: BIO CEO Crowley’s plans for Trump 2.0
BIO is engaging Trump to protect and improve FDA, hoping to dodge tariffs, looking for paths to modify IRA and reinstate PRVs
The last seven weeks in Washington have felt like a year; it seems like a lifetime has passed since last March, when John Crowley joined BIO as its president and CEO.
BioCentury sat down with Crowley Thursday to talk about how he’s navigating the most tumultuous presidential transition in modern history. ...